Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
01/2011
01/19/2011EP2275550A2 Variants of ADP-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
01/19/2011EP2275547A2 Polynucleotides and polypeptide sequences involved in the process of bonne remodeling
01/19/2011EP2275546A2 Enzymatic DNA molecules
01/19/2011EP2275536A1 AP1 amine oxidase variants
01/19/2011EP2275522A2 Enzymatic oil-degumming method
01/19/2011EP2275432A1 Nanofiltration of factor VII solutions to remove virus
01/19/2011EP2274446A2 Two slow-step polymerase enzyme systems and methods
01/19/2011EP2274432A1 A method for the production of a human protein in a plant, in particular a human recombinant lysosomal enzyme in a cereal endosperm
01/19/2011EP2274431A1 Plants having enhanced yield-related traits and a method for making the same
01/19/2011EP2274429A1 Multizymes
01/19/2011EP2274428A1 Isolated peptides having phospholipase inhibitory activity
01/19/2011EP2274417A2 Cellular production of glucaric acid
01/19/2011EP2274324A1 Substances and compositions for enhancing dna repair and methods of use
01/19/2011EP2274322A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same
01/19/2011EP2083074B1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase
01/19/2011EP1730275B1 Lactobacillus fermentum n-desoxyribosyl transferases and the use thereof for enzymatic synthesis of 2', 3' -didesoxynucleosides and 2',3'-didehydro-2', 3'-didesoxynucleosides
01/19/2011EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
01/19/2011EP1409008B1 Use of a nucleic acid molecule coding the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
01/19/2011EP1326964B1 THERMOSTABLE POLYMERASE BASED ON i THERMOCOCCUS PACIFICUS /i
01/19/2011EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
01/19/2011EP1224299B1 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics
01/19/2011EP1132475B1 Novel serine protease bssp2
01/19/2011EP1027418B2 Cleaning compositions containing multiply-substituted protease variants
01/19/2011CN101952439A Expression system used for the antibiotic-free production of polypeptides
01/19/2011CN101952437A Xylanases, nucleic acids encoding them and methods for making and using them
01/19/2011CN101952428A Mutant pyrrolysyl-tRNA synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same
01/19/2011CN101952424A New proteins for use in human and animal staphylococcus infections
01/19/2011CN101952423A Mutated nucleotide sequences of batroxobin, mutated alpha factor secretion signal sequence and processes for preparing batroxobin using the same
01/19/2011CN101952422A Chemically modified factor IX
01/19/2011CN101952421A Polypeptides having endoglucanase activity and polynucleotides encoding same
01/19/2011CN101952420A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
01/19/2011CN101952419A Novel gene sms 43
01/19/2011CN101952418A Process for producing (2S,3R,4S)-4-hydroxy-L-isoleucine
01/19/2011CN101952417A Enzyme involved in synthesis of equol
01/19/2011CN101952414A Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
01/19/2011CN101952413A Method for stonewashing fabrics using cellulase
01/19/2011CN101952409A Brewing process
01/19/2011CN101952304A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
01/19/2011CN101948854A Lactase mutator, secretory expression method and application thereof
01/19/2011CN101948853A Thermophilic fat bacillus DNA polymerase
01/19/2011CN101948852A Piemarker epsps gene and application thereof
01/19/2011CN101948841A Epitope sequences
01/19/2011CN101948821A Method for producing alpha-acetolacetate decearboxylase by using integrated recombinant bacillus subtilis as strain
01/19/2011CN101948820A Acidic proteinase and preparation method thereof
01/19/2011CN101948819A Oxyneurin metabolic plant tyrosine phosphatase protein, coding gene thereof and use thereof
01/19/2011CN101948818A N-acetyl homoserine lactonase-xylanase fusion protein and coding gene and application thereof
01/19/2011CN101948817A Enzyme for degrading acephate pesticides, coding gene, expression vector, industrial bacterial strain and application thereof
01/19/2011CN101948795A Engineering bacteria of soluble expression Not I, and construction method and application thereof
01/19/2011CN101948542A Nanoliposome antivenom active enzyme A2 and enteropathogen specific composite IgY and application thereof
01/19/2011CN101948509A Affinity peptide for tissue-type plasminogen activator and fragment of activator, and application thereof
01/19/2011CN101514336B Method for producing renninum by solid-state fermentation of red yeast rice
01/18/2011USRE42046 granular starch hydrolyzing comprising isolated acid stable alpha amylase and glucoamylase; from Trichoderma
01/18/2011US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer
01/18/2011US7872111 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
01/18/2011US7872104 Antibody, immunoassay and method for prostate cancer detection
01/18/2011US7872100 Nitrile hydratases from metagenome libraries
01/18/2011US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
01/18/2011US7872047 idebenone octanoate; idebenone conjugated linoleate, idebenone linoleate; dematology; skin roughness, skin wrinkles, photodamaged skin, skin hyperpigmentation, skin irritation and skin inflammatory reaction
01/18/2011US7871992 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
01/18/2011US7871986 provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines
01/18/2011US7871806 Asparaginases
01/18/2011US7871805 Glucose dehydrogenase
01/18/2011US7871804 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms
01/18/2011US7871803 from plankton Metridia pacifica; blue luminescence
01/18/2011US7871802 process to protect and/or increase the specific activity of an enzyme (nitrilase) catalyst comprising a polypeptide having nitrilase activity when converting glycolonitrile to glycolic acid by conducting the reaction in the presence of an amine protectant
01/18/2011US7871801 L-amino acid-producing bacterium and a method for producing L-amino acids
01/18/2011US7871800 Polypeptides having glucoamylase activity and polynucleotides encoding same
01/18/2011US7871797 proteolysis; recombinant vectors; transformants
01/18/2011US7871795 Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
01/18/2011US7871790 Anthrax bioassays and methods of treating and diagnosing anthrax infection
01/18/2011US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents
01/18/2011US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications
01/18/2011US7871763 gene expression; probes, primers, antibodies
01/18/2011US7871608 Reversibly inactivated acidified plasmin
01/18/2011US7871607 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant soluble neutral active Hyaluronidase Glycoproteins to enhance stability and serum pharmacokinetics over natural slaughterhouse enzymes; transgenic animals; dosage forms
01/18/2011CA2455145C Pregnancy-related serine protease
01/18/2011CA2402893C .alpha.-amylase activity inhibitor
01/18/2011CA2338665C Peg-urate oxidase conjugates and use thereof
01/18/2011CA2319754C Glycosyltransferase and dna encoding the same
01/18/2011CA2212832C Thrombin preparation
01/18/2011CA2192195C Modification of starch content in plants
01/18/2011CA2191053C A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence
01/18/2011CA2156976C Genetic sequences encoding glucocorticoid dehydrogenases and uses therefor
01/13/2011WO2011005867A1 Polypeptides having cellulolytic enhancing activity activity and polynucleotides encoding same
01/13/2011WO2011005823A1 Crystal structure of glyphosate acetyltransferase (glyat) and methods of use
01/13/2011WO2011005762A1 Chemically modified ligase cofactors, donors and acceptors
01/13/2011WO2011005527A2 Ketoreductase-mediated stereoselective route to alpha chloroalcohols
01/13/2011WO2011005477A1 Transaminase reactions
01/13/2011WO2011004654A1 Glucose dehydrogenase derived from mucor microorganism
01/13/2011WO2011004129A1 Use of a co-product from a method for extracting lysozyme from egg whites, in order to obtain at least one basic egg white protein
01/13/2011WO2011004011A1 Variants of plasminogen and plasmin
01/13/2011WO2011003886A1 Pegylated l-asparaginase
01/13/2011WO2011003809A1 Role of pld1 in thrombus formation and integrin alpha iib beta 3 activation
01/13/2011WO2011003784A1 Flocculation with divalent salt and phosphate
01/13/2011WO2011003703A1 Stabilized enzyme compositions
01/13/2011WO2011003702A1 Stabilized enzyme compositions
01/13/2011WO2011003633A1 Pegylated l-asparaginase
01/13/2011WO2011003153A1 Method of increasing the expression yield of vitamin k-dependent proteins
01/13/2011WO2010122532A3 Feed supplement
01/13/2011WO2010122135A3 Use of mixed lineage like kinase polypeptides (mlkl polypeptides) in cancer therapy